Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PDD vs MRNA✓SelectedUSD · MRNAPDD vs MRNA performance historyLatest closeAs of-2.70%11/20
Stock and ETF performance explorer

PDD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-29.6%
MRNA return
+153.9%
Excess return
-183.5%
Maximum drawdown
-53.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.7%-2.2%-0.5%-2.6%
7D+6.0%-12.7%+18.7%+6.6%
30D+6.3%-20.7%+27.0%+7.1%
3M-6.5%+46.3%-52.8%-8.4%
6M-14.7%+305.2%-320.0%-24.3%
YTD-26.2%+561.2%-587.4%-39.1%
1Y-25.9%+772.1%-798.0%-41.2%
3Y-29.6%+147.0%-176.5%-34.0%
All-29.6%+153.9%-183.5%-34.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling